Treatment of Anemia in Myelodysplastic Syndromes With Granulocyte Colony-Stimulating Factor Plus Erythropoietin: Results From a Randomized Phase II Study and Long-Term Follow-Up of 71 PatientsEva Hellström-Lindberg, Åke Öst, Jan Carneskog et al.|Blood|1998Cited by 306
Zanubrutinib for the treatment of patients with del(17p) and/or <i>TP53</i> CLL/SLL: analysis across clinical studiesConstantine S. Tam, Jennifer R. Brown, Mary Ann Anderson et al.|Blood Advances|2025Cited by 2